Abstract 2657: DB-1326, a novel dual-payload TA-MUC1-directed antibody-drug conjugate, shows potent antitumor efficacy in pre-clinical tumor model
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Chenggang Li, Lei Yi, Jun Yao, Yang Qiu, Haiqing Hua
Institution: Duality Biotherapeutics, Inc. (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148807431
Cites:
Cited by:
Related to:
